Prognostic impact of concomitant loss of PBRM1 and BAP1 protein expression in early stages of clear cell renal cell carcinoma
Urologic Oncology: Seminars and Original Investigations | Feb 13, 2018
CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma
Urologic Oncology: Seminars and Original Investigations | Jan 25, 2018
Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy
Urologic Oncology: Seminars and Original Investigations | Dec 04, 2017
PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient's overall survival
Urologic Oncology: Seminars and Original Investigations | Nov 24, 2017